Last $94.90 USD
Change Today -2.03 / -2.09%
Volume 2.0M
QCOR On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 4:30 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

questcor pharmaceuticals (QCOR) Snapshot

Open
$95.73
Previous Close
$96.93
Day High
$97.80
Day Low
$94.19
52 Week High
07/14/14 - $97.80
52 Week Low
07/25/13 - $46.00
Market Cap
5.8B
Average Volume 10 Days
1.5M
EPS TTM
$5.98
Shares Outstanding
61.4M
EX-Date
06/27/14
P/E TM
15.9x
Dividend
$1.20
Dividend Yield
1.26%
Current Stock Chart for QUESTCOR PHARMACEUTICALS (QCOR)

questcor pharmaceuticals (QCOR) Related Businessweek News

No Related Businessweek News Found

questcor pharmaceuticals (QCOR) Details

Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of autoimmune and inflammatory disorders. The company primarily offers H.P. Acthar Gel, an injectable drug to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus; as exacerbation or maintenance therapy in various cases of systemic lupus erythematosus and systemic dermatomyositis; and as adjunctive therapy for short-term administration in psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis. Its H.P. Acthar Gel is also used for the treatment of acute exacerbations of multiple sclerosis in adults; and as monotherapy for the treatment of infantile spasms in infants and children under two years of age. The company sells its product primarily to specialty pharmacies. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.

490 Employees
Last Reported Date: 04/29/14
Founded in 1990

questcor pharmaceuticals (QCOR) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $832.0K
Chief Operating Officer
Total Annual Compensation: $520.0K
Executive Vice President of Strategic Affairs...
Total Annual Compensation: $485.0K
Chief Technical Officer and Executive Vice Pr...
Total Annual Compensation: $468.0K
Chief Scientific Officer
Total Annual Compensation: $520.0K
Compensation as of Fiscal Year 2013.

questcor pharmaceuticals (QCOR) Key Developments

Questcor Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Questcor Pharmaceuticals, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, total net sales were $278,830,000 against $184,573,000 a year ago. Income from operations was $147,764,000 against $103,072,000 a year ago. Income before income taxes was $147,598,000 against $103,092,000 a year ago. Net income was $96,436,000 against $69,123,000 a year ago. Diluted income per share was $1.54 against $1.12 a year ago. Adjusted net income was $115,822,000 against $83,323,000 a year ago. Adjusted net income per diluted share was $1.85 against $1.35 a year ago. Adjusted consolidated net sales $278,830,000 against $196,073,000 a year ago. Cash flow from operations was $99 million compared to $82 million a year ago. For the six months, Total net sales were $505,934,000 against $319,702,000 a year ago. Income from operations was $261,627,000 against $161,419,000 a year ago. Income before income taxes was $260,515,000 against $160,609,000 a year ago. Net income was $170,746,000 against $108,185,000 a year ago. Diluted income per share was $2.75 against $1.79 a year ago. Adjusted net income was $202,083,000 against $128,987,000 a year ago. Adjusted net income per diluted share was $3.25 against $2.13 a year ago. Adjusted consolidated net sales $505,934,000 against $331,202,000 a year ago. Net cash flows provided by operating activities was $205,431,000 against $122,991,000 a year ago. Purchase of property and equipment was $8,266,000 against $1,138,000 a year ago.

Questcor Pharmaceuticals, Inc.(NasdaqGS:QCOR) added to Russell 1000 Index

Questcor Pharmaceuticals, Inc. will be added to the Russell 1000 Index.

Questcor Pharmaceuticals, Inc.(NasdaqGS:QCOR) dropped from Russell 2000 Index

Questcor Pharmaceuticals, Inc. will be removed from the Russell 2000 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QCOR:US $94.90 USD -2.03

QCOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $13.11 USD -0.15
CR Bard Inc $148.85 USD +1.90
Novartis AG SFr.79.95 CHF -0.45
Sanofi €75.98 EUR -1.34
View Industry Companies
 

Industry Analysis

QCOR

Industry Average

Valuation QCOR Industry Range
Price/Earnings 18.1x
Price/Sales 6.4x
Price/Book 12.1x
Price/Cash Flow 17.6x
TEV/Sales 6.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUESTCOR PHARMACEUTICALS, please visit www.questcor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.